IHS Chemical Week

Regions :: Western Europe :: Germany

BASF to acquire US enzyme biotechnology company Verenium

4:45 AM MDT | September 20, 2013 | Deepti Ramesh

BASF says that its BASF Corp. subsidiary has entered into an agreement to begin a cash tender offer for all the outstanding shares of common stock of industrial biotechnology company Verenium (San Diego), for $4/share. Based on all outstanding shares and including all net financial liabilities, the enterprise value would be about $62 million, BASF says. Verenium, which is focused on the development and commercialization of high-performance enzymes, recorded sales of $57 million in 2012. The offer corresponds to a premium of 56% above the volume-weighted average...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa